首页> 外国专利> 1 1 Formulation composition of once-daily fixed-dose combination bilayer tablets of cilostazol and clopidogrel and manufacturing method thereof

1 1 Formulation composition of once-daily fixed-dose combination bilayer tablets of cilostazol and clopidogrel and manufacturing method thereof

机译:1 1西洛他唑与氯吡格雷每日一次固定剂量组合双层片剂的制剂组成及其制备方法

摘要

The present invention relates to a once-daily twice-daily oral double-layer tablet containing a fixed dose of cilostazol and clopidogrel, and a method for preparing the same, wherein the two-layer tablet comprises a cilostazol emulsion layer and a clopidogrel emitter layer, Because the starzole emissive layer can contain a fixed amount of cilostazol and clopidogrel by including certain amounts of polyethylene oxide and Eudragit RS as the release agent, it is possible to provide a two-layered tablet that can be taken orally once a day, It can be widely used as an aged personalized preparation in which vascular diseases are frequently caused.
机译:本发明涉及含有固定剂量西洛他唑和氯吡格雷的每日一次每日两次口服双层片剂及其制备方法,其中该两层片剂包括西洛他唑乳剂层和氯吡格雷发射体层。由于通过包含一定量的聚环氧乙烷和Eudragit RS作为脱模剂,该星唑发光层可以包含固定量的西洛他唑和氯吡格雷,因此可以提供一种每天口服一次的两层片剂,可以广泛用作经常引起血管疾病的老化的个性化制剂。

著录项

  • 公开/公告号KR101843396B1

    专利类型

  • 公开/公告日2018-03-29

    原文格式PDF

  • 申请/专利权人 가톨릭대학교 산학협력단;

    申请/专利号KR20160119456

  • 发明设计人 오의철;응유엔 딘 콴;문철;

    申请日2016-09-19

  • 分类号A61K9/20;A61K31/41;A61K31/4365;A61K31/4704;A61K9;

  • 国家 KR

  • 入库时间 2022-08-21 12:38:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号